Operating cash flow increased 83.1%
Operating cash flow changed +83.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow changed +83.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Shares outstanding changed +345.0% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
Cash & equivalents changed -98.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed -92.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed -96.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed +314.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Research & development changed -94.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current liabilities changed +105.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital / assets changed -7709 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating income changed -1.0% from the comparable as-filed period.
Stock-based compensation changed -116.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 3 consecutive comparable moves in the opposite direction.
Working capital changed -188.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Operating income changed +24.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Research & development changed -83.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Stock-based compensation changed -93.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Shares outstanding changed -46.7% from the comparable as-filed period. The change ranks at the 50th percentile of 6 prior comparable changes.
Cash & equivalents changed -75.8% from the comparable as-filed period.
Current ratio changed -89.3% from the comparable as-filed period.
Current liabilities changed +366.0% from the comparable as-filed period.
Current assets changed -50.3% from the comparable as-filed period.
Working capital / assets changed -10931 basis points from the comparable as-filed period.
Total assets changed +122.4% from the comparable as-filed period.
Operating cash flow changed +4.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Working capital changed -283.9% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.